Newly emerged immunogenic neoantigens in established tumors enable hosts to regain immunosurveillance in a T-cell-dependent manner

  • Muramatsu, Tomoaki
  • Noguchi, Takuro
  • Sugiyama, Daisuke
  • Kanada, Yoshie
  • Fujimaki, Kaori
  • Ito, Sachiko
  • Gotoh, Momokazu
  • Nishikawa, Hiroyoshi

  • Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Department of Medical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    Division of Cancer Immunology, Research Institute, National Cancer Center, Tokyo, Japan

    Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Chiba, Japan

Correspondence to: H. Nishikawa; E-mail: [email protected]

Received June 17, 2020

Accepted July 25, 2020

Revised August 24, 2020

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

International Immunology 33(1):p 39-48, January 2021. | DOI: 10.1093/intimm/dxaa049

Corresponding Article

In This Issue

International Immunology 33(1):p 5-6, January 2021. | DOI: 10.1093/intimm/dxaa074
Copyright © The Japanese Society for Immunology 2021. Published by Oxford University Press. All rights reserved.
View full text|Download PDF